1. NBF2, an Algal Fiber-Rich Formula, Reverses Diabetic Dyslipidemia and Hyperglycemia In Vivo.
- Author
-
Ngatu NR, Hossain A, Maruo N, Akumwami S, Rahman AM, Eitoku M, Kanda K, Nishiyama A, Suganuma N, and Hirao T
- Subjects
- Animals, Rats, Male, Blood Glucose metabolism, Blood Glucose drug effects, Dietary Fiber pharmacology, Rats, Inbred OLETF, Insulin Resistance, Hyperglycemia drug therapy, Dyslipidemias drug therapy, Diabetes Mellitus, Type 2 drug therapy, Diabetes Mellitus, Type 2 metabolism
- Abstract
Ulva prolifera , known as Aonori in Japan, is an edible alga species that is mass-cultivated in Japan. Supplementation with Aonori-derived biomaterials has been reported to enhance metabolic health in previous studies. This was an experimental study that evaluated the metabolic health effects of NBF2, a formula made of algal and junos Tanaka citrus -derived biomaterials, on obesity and type 2 diabetes (T2DM). We used 18 obese and hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) rats that were assigned randomly to three groups of six animals: a high-dose NBF2 drink (20 mg/kg) group, a low-dose (10 mg/kg) NBF2 drink group and the control group that received 2 mL of tap water daily for a total of six weeks. We also used eight LETO rats as the normal control group. In addition to the glucose tolerance test (OGTT), ELISA and real-time PCR assays were performed. High-dose and lowdose NBF2 improved insulin sensitivity, as well as glycemic and lipid profiles, as compared with control rats. The OGTT showed that both NBF2 groups and LETO rats had normalized glycemia by the 90-min time-point. NBF2 up-regulated PPARα/γ-mRNA and Sirt2-mRNA gene expressions in BAT and improved the blood pressure profile. These findings suggest that the NBF2 formula, which activates PPAR-α/γ mRNA and Sirt2-mRNA, may reverse dyslipidemia and hyperglycemia in T2DM.
- Published
- 2024
- Full Text
- View/download PDF